Urges the Centers for Disease Control and Prevention to include new RSV immunization technologies (including vaccines and monoclonal antibodies), within the federal VFC program if the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention issues administrative recommendations that are subsequently approved by the Director of the Centers for Disease Control and Prevention.